SCAVENGER RECEPTOR B1 (CLA-1) TARGETING FOR THE TREATMENT OF INFECTION, SEPSIS AND INFLAMMATION

Details for Australian Patent Application No. 2003287288 (hide)

Owner THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH

Inventors BOCHAROV, Alexander, V.; BARANOVA, Irina, N.; CSAKO, Gyorgy; EGGERTON, Thomas, L.; PATTERSON, Amy, L.; REMALEY, Alan,T.; VISHNYAKOVA, Tatyana, V.

Pub. Number AU-A-2003287288

PCT Number PCT/US2003/0345

PCT Pub. Number WO2004/041179

Priority 60/422,105 30.10.02 US

Filing date 30 October 2003

Wipo publication date 7 June 2004

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/422,105 30.10.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-A-2003287288

21 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287289-Promotion of peroxisomal catalase function in cells

2003287287-Controlling multiple modems in a wireless terminal using dynamically varying modem transmit power limits